<DOC>
	<DOCNO>NCT02341066</DOCNO>
	<brief_summary>To evaluate contribution assessment endothelial dysfunction ( ED ) improve coronary hearth disease ( CHD ) risk stratification obtain Framingham risk score ( FRS ) rheumatoid arthritis population ( RA ) .</brief_summary>
	<brief_title>Endothelial Dysfunction Evaluation Coronary Heart Disease Risk Estimation Rheumatoid Arthritis ( EDRA Study )</brief_title>
	<detailed_description>ED , determine peripheral arterial tonometry ( PAT ) , evaluate baseline 3000 RA patient free previous cardiovascular event . Incident CHD event 3-year plan follow-up registered . A measure incremental yield ED obtain compare 2-year Framingham risk score CHD ( FRS ) FRS plus ED differential prognostic performance C-statics risk reclassification analysis .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>RA define American College Rheumatology/European League Against Rheumatisms 2010 RA classification criterion In opinion investigator , patient must able adhere study visit schedule must capable give informed consent Previous cardiovascular cerebrovascular event ( acute coronary syndrome , stable angina , stroke , interventional procedure , carotid endarterectomy , symptomatic peripheral artery ischemia ) Pathological ECG rest Sign symptom autonomous nervous system dysfunction Serious infection previous 6 month Concomitant severe illness : overt hepatic insufficiency ; End stage renal disease ( Glomerular Filtration Rate &lt; 30 ml/h CockroftsGault formula ) ; recent diagnosis cancer Pregnancy Plans leave target area study site within three year</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Cardiovascular risk score</keyword>
	<keyword>Framingham risk score 2-year</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>EndoPAT</keyword>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>